WHO - Guideline for clinical management of exposure to lead [2021]
Description:
The purpose of this guideline is to assist physicians in making decisions about the diagnosis and treatment of lead exposure. The guideline presents evidence-informed recommendations on (i) the interpretation of blood lead concentrations; (ii) use of gastrointestinal decontamination; (iii) use of a chelating agent; and (iv) use of nutritional supplements.
Why this Tool/Guidance?
Information provided is useful to support physicians in making decisions about the diagnosis and treatment of lead exposure for individual patients and in mass poisoning incidents. It can also be used to provide an authoritative basis for the development of national programmes for the diagnosis and management of lead poisoning.
Continue to: